NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
GOSS Gossamer Bio
- 1.230
- +0.040+3.36%
Close Feb 28 16:00 ET
- 1.250
- +0.020+1.63%
Post 20:01 ET
278.72MMarket Cap-4.92P/E (TTM)
1.230High1.100Low1.47MVolume1.140Open1.190Pre Close1.73MTurnover0.80%Turnover RatioLossP/E (Static)226.60MShares1.60052wk High5.15P/B225.16MFloat Cap0.49952wk Low--Dividend TTM183.05MShs Float27.150Historical High--Div YieldTTM10.92%Amplitude0.453Historical Low1.172Avg Price1Lot Size
Gossamer Bio News
Is Gossamer Bio (NASDAQ:GOSS) Weighed On By Its Debt Load?
Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges
Gossamer Bio's Strategic Focus on PAH Unmet Needs and Seralutinib Efficacy Drives Buy Rating
12 Health Care Stocks Moving In Thursday's Pre-Market Session
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
Gossamer Bio (GOSS) Gets a Buy From Oppenheimer
Express News | HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Gossamer Bio Analyst Ratings
Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations
Gossamer Bio: Q3 Earnings Snapshot
Earnings Flash (GOSS) GOSSAMER BIO Reports Q3 Revenue $9.5M
Gossamer Bio | 10-Q: Q3 2024 Earnings Report
Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Gossamer Bio 3Q Loss/Shr 14c >GOSS
Express News | Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Express News | Gossamer Bio Q3 Operating Expenses USD 43.399 Million
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)